| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/10/2009 | US20090226488 Vaccine comprising an attenuated pestivirus |
| 09/10/2009 | US20090226487 Avian embryo particulate biomass for the production of virus antigens |
| 09/10/2009 | US20090226486 N protein mutants of porcine reproductive and respiratory syndrome virus |
| 09/10/2009 | US20090226485 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus |
| 09/10/2009 | US20090226484 Immunogenic LHRH compositions and methods relating thereto |
| 09/10/2009 | US20090226480 Streptococcus uberis adhesion molecule |
| 09/10/2009 | US20090226479 Vaccines and their use |
| 09/10/2009 | US20090226478 Early detection of flaviviruses using the NS1 glycoprotein |
| 09/10/2009 | US20090226477 Pth2 receptor selective compounds |
| 09/10/2009 | US20090226476 Human Glycoform |
| 09/10/2009 | US20090226475 Peptide-based immunization therapy for treatment of atherosclerosis |
| 09/10/2009 | US20090226474 Antibodies as T cell receptor mimics, methods of production and uses thereof |
| 09/10/2009 | US20090226473 Lymphocyte surface receptor that binds caml and methods of use thereof |
| 09/10/2009 | US20090226472 Interleukin-4 receptors |
| 09/10/2009 | US20090226471 Methods of mhc class ii epitope mapping, detection of autoimmune t cells and antigens, and autoimmune treatment |
| 09/10/2009 | US20090226470 Compositions and methods related to mRNA translational enhancer elements |
| 09/10/2009 | US20090226469 Shiga Toxoid Chimeric Proteins |
| 09/10/2009 | US20090226468 Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the CNS |
| 09/10/2009 | US20090226467 De novo synthesis of bacteriochlorins |
| 09/10/2009 | US20090226466 Therapeutic anti-her2 antibody fusion polypeptides |
| 09/10/2009 | US20090226465 Macrocyclic depsipeptide antibody-drug conjugates and methods |
| 09/10/2009 | US20090226464 Immunoglobulins comprising predominantly a glcnacman3glcnac2 glycoform |
| 09/10/2009 | US20090226463 Novel method of modulating bone-related activity |
| 09/10/2009 | US20090226462 use of polypeptide in a vaccine for protection of fish from Aeromomas |
| 09/10/2009 | US20090226461 IL1-Beta Binding Antibodies and Fragments thereof |
| 09/10/2009 | US20090226460 Compositions and methods for the treatment of disease |
| 09/10/2009 | US20090226459 Role of fgf-19 in cancer diagnosis and treatment |
| 09/10/2009 | US20090226458 Screening For Anti-Cancer Compounds Using Netrin-1 Activity |
| 09/10/2009 | US20090226457 antibody that is immunoreactive with a polypeptide used in treating autoimmune and immunological diseases |
| 09/10/2009 | US20090226456 screening methods for identifying agonists and antagonists of TNFR-6 alpha & -6 beta activity; diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders; cancer |
| 09/10/2009 | US20090226455 Combination therapy with c-met and her antagonists |
| 09/10/2009 | US20090226454 Antibodies against a peptide epitope of apoliporotein b |
| 09/10/2009 | US20090226453 Sphingosine 1-phosphate antagonism |
| 09/10/2009 | US20090226452 Method for enhancing or inhibiting insulin-like growth factor-i |
| 09/10/2009 | US20090226451 Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor |
| 09/10/2009 | US20090226450 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor |
| 09/10/2009 | US20090226449 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921, and 33751 molecules and uses therefor |
| 09/10/2009 | US20090226448 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor |
| 09/10/2009 | US20090226447 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof |
| 09/10/2009 | US20090226446 Method to Inhibit the Propagation of an Undesired Cell Population |
| 09/10/2009 | US20090226445 Plasmodium malariae and plasmodium ovale genes and uses thereof |
| 09/10/2009 | US20090226444 Pharmaceutical antibody compositions with resistance to soluble cea |
| 09/10/2009 | US20090226443 Combination therapy with c-met and egfr antagonists |
| 09/10/2009 | US20090226442 RON antibodies and uses thereof |
| 09/10/2009 | US20090226441 Activin receptor-like kinase-1 compositions and methods of use |
| 09/10/2009 | US20090226440 Prophylactic and/or Therapeutic Method for Treatment of Autoimmune Disease |
| 09/10/2009 | US20090226439 Method for treating dementia or alzheimer's disease |
| 09/10/2009 | US20090226438 Polypeptides and Antibodies |
| 09/10/2009 | US20090226437 Humanized anti-beta7 antagonists and uses therefor |
| 09/10/2009 | US20090226436 Novel receptors |
| 09/10/2009 | US20090226435 Engineered fusion molecules immunotherapy in cancer and inflammatory diseases |
| 09/10/2009 | US20090226434 Afucosylated antibodies against CCR5 and their use for the treatment of inflammatory conditions |
| 09/10/2009 | US20090226433 Compositions and methods for the therapy and diagnosis of influenza |
| 09/10/2009 | US20090226432 Pharmaceutical compositions with resistance to soluble cea |
| 09/10/2009 | US20090226431 Treatment of Cancer and Other Diseases |
| 09/10/2009 | US20090226430 Recombinant anti-cd4 antibodies for human therapy |
| 09/10/2009 | US20090226429 Antibodies That Immunospecifically Bind to TRAIL Receptors |
| 09/10/2009 | US20090226428 Anti-inflammatory dab |
| 09/10/2009 | US20090226427 Novel pharmaceutical compositions for modulating angiogenesis |
| 09/10/2009 | US20090226426 Method for treating inflammation |
| 09/10/2009 | US20090226425 Diagnostics and Therapeutics For Glaucoma |
| 09/10/2009 | US20090226424 Subdermal tissue remodeling using myostatin, methods and related systems |
| 09/10/2009 | US20090226423 Protein kinase C as a target for the treatment of respiratory syncytial virus |
| 09/10/2009 | US20090226422 Chemical Inhibitors of Inhibitors of Differentiation |
| 09/10/2009 | US20090226421 Recombinant monovalent antibodies and methods for production thereof |
| 09/10/2009 | US20090226420 Methods of Determining the Risk of Developing Coronary Artery Disease |
| 09/10/2009 | US20090226418 Food Products Comprising Probiotic Micro-Organisms and Antibodies |
| 09/10/2009 | US20090226417 Human B7 polypeptides |
| 09/10/2009 | US20090226416 Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
| 09/10/2009 | US20090226399 Medicaments comprising gene recombinant antibody against ganglioside gd3 |
| 09/10/2009 | US20090226367 Compositions comprising an anti-ca125 antibody and a cytotoxic compound and their use for the treatment of cancer |
| 09/09/2009 | EP2098589A2 Immune cell modification method and cell modification device |
| 09/09/2009 | EP2098246A1 Method for promoting immune response comprising inhibiting cd22 function in b cells |
| 09/09/2009 | EP2097534A2 Human antibodies that bind cd70 and uses thereof |
| 09/09/2009 | EP2097517A2 Modified vaccinia virus strains for use in diagnostic and therapeutic methods |
| 09/09/2009 | EP2097454A2 4-1 bb ligand in inflammatory diseases |
| 09/09/2009 | EP2097453A2 Monoclonal antibodies against the human anti-müllerian hormone type ii receptor (amhr-ii) |
| 09/09/2009 | EP2097450A2 Antibody-based diagnostics and therapeutics |
| 09/09/2009 | EP2097448A2 Method of detecting ocular diseases and pathologic conditions and treatment of same |
| 09/09/2009 | EP2097447A2 Human monoclonal antibodies to btla and methods of use |
| 09/09/2009 | EP2097446A2 Resistin antagonists and their use |
| 09/09/2009 | EP2097106A2 Novel uses and methods |
| 09/09/2009 | EP2097105A2 Anti-p-selectin antibodies and methods of using the same to treat inflammatory diseases |
| 09/09/2009 | EP2097104A2 New a-beta conformer selective anti-a-beta globulomer monoclonal antibodies |
| 09/09/2009 | EP2097103A1 Influenza vaccine formulation |
| 09/09/2009 | EP2097102A2 Combination vaccine having reduced polio virus antigen quantities |
| 09/09/2009 | EP2097101A2 Tbpb proteins in attenuated oral live vaccines |
| 09/09/2009 | EP2097100A1 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
| 09/09/2009 | EP2097099A1 Novel compositions and uses thereof |
| 09/09/2009 | EP2097098A1 Expression of transgenic t cell receptors in lak-t cells |
| 09/09/2009 | EP2097097A2 Human antibodies that bind cd22 and uses thereof |
| 09/09/2009 | EP2097090A2 Peptide and treatment for hiv-1 infection |
| 09/09/2009 | EP2097078A1 Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer |
| 09/09/2009 | EP1723246B1 New expression tools for multiprotein applications |
| 09/09/2009 | EP1654272B1 Ra antigenic peptides |
| 09/09/2009 | EP1651260B1 Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof |
| 09/09/2009 | EP1648505B1 Quil a fraction with low toxicity and use thereof |
| 09/09/2009 | EP1578958B1 Method for suppressing immune system response to transplanted tissue or cells |
| 09/09/2009 | EP1578382B1 Botulinum neurotoxin b receptors and use thereof |
| 09/09/2009 | EP1523330B1 Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells |